Invoices for C-II's, C-III's, C-IV's, and C-V's must be filed together. Is this statement true or false?

Study for the Ohio Multistate Pharmacy Jurisprudence Examination (MPJE). Utilize flashcards and multiple choice questions with explanations to prepare for your exam effectively!

The statement is false; invoices for controlled substances, including C-II, C-III, C-IV, and C-V drugs, must be filed separately. In the context of the regulations governing the handling of controlled substances in pharmacies, each schedule has specific requirements and regulations regarding record-keeping and inventory management.

C-II drugs, due to their higher potential for abuse and associated stringent regulatory controls, have separate record-keeping requirements compared to C-III, C-IV, and C-V drugs. This separation helps facilitate accurate tracking and monitoring of these medications, ensuring compliance with federal and state laws. While C-III, C-IV, and C-V drugs may be grouped together for certain record-keeping purposes because they share lower restrictions, invoices related to C-II substances must always be maintained in a distinct file.

This distinction is crucial for maintaining compliance with regulatory requirements and ensuring the accurate auditing of pharmacy operations.